PreDxion Bio Company
PreDxion Bio aims to revolutionize critical care medicine by providing ICU doctors with actionable patient immune function data
Industry:
P4 Medicine
Investors Number:
3
Technology:
Other
Last Funding Type:
Seed
Headquarters:
Others
Founded Date:
2016-02-02
Investor Type:
For Profit
Funding Status:
Seed
Total Funding:
$120K
Estimated Revenue:
Less than $1M
Employee Number:
1-10